Shares of NuVasive, Inc. (NUVA), a developer of minimally disruptive surgical products for spine surgery, are declining more than 7 percent or $3.51 in Friday's morning trade at $45.76 despite its third-quarter results beating analysts' estimates.
from RTT - Earnings https://ift.tt/34GQeLT
via IFTTT
No comments:
Post a Comment